
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prostate Cancer—Focus on Cholesterol
Lucija Škara, Ana Huđek, Ivan Pezelj, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4696-4696
Open Access | Times Cited: 32
Lucija Škara, Ana Huđek, Ivan Pezelj, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4696-4696
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Associations between “Cancer Risk”, “Inflammation” and “Metabolic Syndrome”: A Scoping Review
Elsa Vitale, Alessandro Rizzo, Kazuki Santa, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 352-352
Open Access | Times Cited: 18
Elsa Vitale, Alessandro Rizzo, Kazuki Santa, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 352-352
Open Access | Times Cited: 18
SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance
Guojiang Wei, Ying Huang, Wenya Li, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Guojiang Wei, Ying Huang, Wenya Li, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor’s Immune Environment
Aino Siltari, Heimo Syvälä, Yan‐Ru Lou, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4293-4293
Open Access | Times Cited: 28
Aino Siltari, Heimo Syvälä, Yan‐Ru Lou, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4293-4293
Open Access | Times Cited: 28
Relationship between Cholesterol-Related Lipids and Severe Acute Pancreatitis: From Bench to Bedside
Xiaoying Zhou, Shengchun Jin, Jingyi Pan, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1729-1729
Open Access | Times Cited: 14
Xiaoying Zhou, Shengchun Jin, Jingyi Pan, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1729-1729
Open Access | Times Cited: 14
Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications
Milica Zeković, Uroš Bumbaširević, Marko Živković, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1391-1391
Open Access | Times Cited: 13
Milica Zeković, Uroš Bumbaširević, Marko Živković, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1391-1391
Open Access | Times Cited: 13
A Cu‐Based Single‐Atom Nanozyme Platform with Multi‐Enzyme Simulated Activities for Immunotherapy of Prostate Cancer by Regulating Cholesterol Metabolism and Triggering Pyroptosis
Bo Xu, Rui Niu, Ruiping Deng, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 46
Closed Access | Times Cited: 5
Bo Xu, Rui Niu, Ruiping Deng, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 46
Closed Access | Times Cited: 5
The tangled web of dyslipidemia and cancer
Sina Neshat, Abbas Rezaei, Armita Farid, et al.
Journal of Research in Medical Sciences (2022) Vol. 27, Iss. 1, pp. 93-93
Open Access | Times Cited: 22
Sina Neshat, Abbas Rezaei, Armita Farid, et al.
Journal of Research in Medical Sciences (2022) Vol. 27, Iss. 1, pp. 93-93
Open Access | Times Cited: 22
Thermal proteome profiling and proteome analysis using high‐definition mass spectrometry demonstrate modulation of cholesterol biosynthesis by next‐generation galeterone analog VNPP 433‐3β in castration‐resistant prostate cancer
Retheesh S. Thankan, Elizabeth Thomas, Mehari Muuz Weldemariam, et al.
Molecular Oncology (2025)
Open Access
Retheesh S. Thankan, Elizabeth Thomas, Mehari Muuz Weldemariam, et al.
Molecular Oncology (2025)
Open Access
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access
(−)-Oleuropein as a Novel Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence Suppressor via Targeting PCSK9-LDLR Axis
Nehal A. Ahmed, Mohamed M. Mohyeldin, Hassan Y. Ebrahim, et al.
Nutrients (2025) Vol. 17, Iss. 9, pp. 1445-1445
Open Access
Nehal A. Ahmed, Mohamed M. Mohyeldin, Hassan Y. Ebrahim, et al.
Nutrients (2025) Vol. 17, Iss. 9, pp. 1445-1445
Open Access
MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer
Amy J. Tibbo, Andrew Hartley, Richa Vasan, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 11, pp. 1991-1999
Open Access | Times Cited: 10
Amy J. Tibbo, Andrew Hartley, Richa Vasan, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 11, pp. 1991-1999
Open Access | Times Cited: 10
Plasma total cholesterol concentration and risk of higher‐grade prostate cancer: A nested case‐control study and a dose‐response meta‐analysis
Hui Liu, Irene M. Shui, NaNa Keum, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 7, pp. 1337-1346
Closed Access | Times Cited: 9
Hui Liu, Irene M. Shui, NaNa Keum, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 7, pp. 1337-1346
Closed Access | Times Cited: 9
Research progress of metabolomics in cervical cancer
Yuhan Jia, Kun Zou, Lijuan Zou
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 9
Yuhan Jia, Kun Zou, Lijuan Zou
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 9
A prognostic model based on CLEC6A predicts clinical outcome of breast cancer patients
Li Chen, Deenraj Kush Dhoomun, Qiang Liu, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112411-112411
Closed Access | Times Cited: 2
Li Chen, Deenraj Kush Dhoomun, Qiang Liu, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112411-112411
Closed Access | Times Cited: 2
Lipid metabolism, amino acid metabolism, and prostate cancer: a crucial metabolic journey
Lin Chen, Yuxin Xu, Yuanshuo Wang, et al.
Asian Journal of Andrology (2023) Vol. 26, Iss. 2, pp. 123-134
Open Access | Times Cited: 5
Lin Chen, Yuxin Xu, Yuanshuo Wang, et al.
Asian Journal of Andrology (2023) Vol. 26, Iss. 2, pp. 123-134
Open Access | Times Cited: 5
Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI
Vinay Mathew Thomas, Beverly Chigarira, Georges Gebrael, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Vinay Mathew Thomas, Beverly Chigarira, Georges Gebrael, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Higher genetically predicted triglyceride level increases the bladder cancer risk independent of LDL and HDL levels
Yujia Xi, Yusi Yang, Zhenxing Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Yujia Xi, Yusi Yang, Zhenxing Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma
Hyondeog Kim, Wonyeop Lee, Young-Wook Kim, et al.
Experimental & Molecular Medicine (2024)
Open Access | Times Cited: 1
Hyondeog Kim, Wonyeop Lee, Young-Wook Kim, et al.
Experimental & Molecular Medicine (2024)
Open Access | Times Cited: 1
Prostate secretory protein 94 inhibits sterol binding and export by the mammalian CAP protein CRISP2 in a calcium-sensitive manner
Ola El Atab, Aslihan Ekim Kocabey, Oluwatoyin A. Asojo, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 3, pp. 101600-101600
Open Access | Times Cited: 7
Ola El Atab, Aslihan Ekim Kocabey, Oluwatoyin A. Asojo, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 3, pp. 101600-101600
Open Access | Times Cited: 7
Deregulation of Cholesterol Homeostasis by a Nuclear Hormone Receptor Crosstalk in Advanced Prostate Cancer
Nianxin Yang, Yatian Yang, Zenghong Huang, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3110-3110
Open Access | Times Cited: 6
Nianxin Yang, Yatian Yang, Zenghong Huang, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3110-3110
Open Access | Times Cited: 6
Revealing the Role of Alternariol in the Local Steroidogenesis in Human Prostate Normal and Cancer Cells
Kinga Anna Urbanek, Karolina Kowalska, Dominika Ewa Habrowska‐Górczyńska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9513-9513
Open Access | Times Cited: 3
Kinga Anna Urbanek, Karolina Kowalska, Dominika Ewa Habrowska‐Górczyńska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9513-9513
Open Access | Times Cited: 3
Ferroptosis‐associated cholesterol metabolism regulated by p85α in human bronchial epithelial cells with smoking
Liyang Li, Xiangdong Wang
Clinical and Translational Discovery (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Liyang Li, Xiangdong Wang
Clinical and Translational Discovery (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Revealing the Role of Alternariol in the Local Steroidogenesis in Human Prostate Normal and Cancer Cells
Kinga Anna Urbanek, Karolina Kowalska, Dominika Ewa Habrowska‐Górczyńska, et al.
(2023)
Open Access | Times Cited: 2
Kinga Anna Urbanek, Karolina Kowalska, Dominika Ewa Habrowska‐Górczyńska, et al.
(2023)
Open Access | Times Cited: 2
Natural isoflavone glabridin targets PI3Kγ as an adjuvant to increase the sensitivity of MDA-MB-231 to tamoxifen and DU145 to paclitaxel
Hongyan Lin, Dongxuan Ai, Qingqing Liu, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2023) Vol. 236, pp. 106426-106426
Closed Access | Times Cited: 2
Hongyan Lin, Dongxuan Ai, Qingqing Liu, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2023) Vol. 236, pp. 106426-106426
Closed Access | Times Cited: 2
Statin use and mortality risk in Asian patients with prostate cancer receiving androgen deprivation therapy: A population‐based cohort study
Yan Hiu Athena Lee, Jeffrey Shi Kai Chan, Jeremy Man Ho Hui, et al.
Cancer Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Yan Hiu Athena Lee, Jeffrey Shi Kai Chan, Jeremy Man Ho Hui, et al.
Cancer Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2